azithromycin abz 250 mg filmtabletten
abz-pharma gmbh - geschäftsanschrift - (4238075) - azithromycin-dihydrat - filmtablette - teil 1 - filmtablette; azithromycin-dihydrat (26116) 262,055 milligramm
elvanse adult 70 mg hartkapseln
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - 70 mg - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 70 milligramm
elvanse adult 50 mg hartkapseln
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - 50 mg - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 50 milligramm
elvanse adult 30 mg hartkapseln
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - 30 mg - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 30 milligramm
rivastigmin beta 13,3 mg/24 stunden transdermales pflaster
betapharm arzneimittel gmbh (3364323) - rivastigmin - transdermales pflaster - 13,3 mg/24 stunden - rivastigmin (23590) 19,2 milligramm
demelora 13,3 mg/24 stunden transdermales pflaster
luye pharma ag (8028156) - rivastigmin - transdermales pflaster - teil 1 - transdermales pflaster; rivastigmin (23590) 19,2 milligramm
bylvay
albireo - odevixibat - cholestasis, intrahepatic - gallen- und lebertherapie - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 und 5.
werendi 13,3 mg/24 stunden transdermales pflaster
luye pharma ag (8028156) - rivastigmin - transdermales pflaster - 13,3 mg/24 stunden - teil 1 - transdermales pflaster; rivastigmin (23590) 19,2 milligramm
werendi 4,6 mg/24 stunden transdermales pflaster
luye pharma ag (8028156) - rivastigmin - transdermales pflaster - 4,6 mg/24 stunden - teil 1 - transdermales pflaster; rivastigmin (23590) 6,4 milligramm
werendi 9,5 mg/24 stunden transdermales pflaster
luye pharma ag (8028156) - rivastigmin - transdermales pflaster - 9,5 mg/24 stunden - teil 1 - transdermales pflaster; rivastigmin (23590) 12,8 milligramm